Healthcare


 PYC Therapeutics Advances New Kidney Disease Drug to Human Trials

PYC Therapeutics Advances New Kidney Disease Drug to Human Trials

November 27, 2024 03:50 PM AEDT| By Team Kalkine Media

Highlights:,PYC Therapeutics advances its investigational drug, PYC-003, into human clinical trials for Autosomal Dominant Polycystic Kidney Disease (PKD).,Pre-clinical studies have demonstrated safety, efficacy, and targeted delivery of the drug in...

 Pro Medicus, Technology One, Wisetech, and Xero See Rising Valuations on ASX

Pro Medicus, Technology One, Wisetech, and Xero See Rising Valuations on ASX

November 27, 2024 03:47 PM AEDT| By Team Kalkine Media

Highlights:,ASX technology stocks like Pro Medicus, Technology One, Wisetech Global, and Xero have seen substantial share price growth in 2024.,The S&P/ASX 200 Information Technology sector has outperformed all other sectors in the last 12 months.,A...

 Dengue Trial Breakthrough: Island Pharma Advances to Phase 2b with FDA Backing

Dengue Trial Breakthrough: Island Pharma Advances to Phase 2b with FDA Backing

November 27, 2024 02:34 PM AEDT| By Team Kalkine Media

Highlights,Island Pharma progresses anti-dengue drug ISLA-101 to Phase 2b trials in early 2025,.,No safety concerns reported during Phase 2a trial, clearing the way for,next,stage,.,Study focuses on controlled dengue transmission for consistent resul...

 Cleo Diagnostics Advances Ovarian Cancer Detection Trials

Cleo Diagnostics Advances Ovarian Cancer Detection Trials

November 27, 2024 01:27 PM AEDT| By Team Kalkine Media

Highlights,Cleo Diagnostics adds Royal Women’s Hospital in Melbourne to its trial network,.,U.S. trials are progressing toward an FDA submission slated for 2025,.,The trial aims to enhance early detection and better health outcomes for women,.,Cleo D...

 Pro Medicus Secures $24 Million US Contract, Still Share Price Dip

Pro Medicus Secures $24 Million US Contract, Still Share Price Dip

November 27, 2024 01:18 PM AEDT| By Team Kalkine Media

Highlights,Pro Medicus announces a $24 million, five-year contract extension with NYU Langone Health.,Expansion includes full-stack cloud migration of the institution’s imaging system.,Continued growth in North America with nine new contracts secured...

 Dengue Fever Treatment Trial: Promising Results for ISLA-101 by Island Pharmaceuticals (ASX:ILA)

Dengue Fever Treatment Trial: Promising Results for ISLA-101 by Island Pharmaceuticals (ASX:ILA)

November 27, 2024 12:41 PM AEDT| By Team Kalkine Media

Highlights,Island Pharmaceuticals reports positive Phase 2a trial results for ISLA-101,.,Evidence of anti-viral activity and safety profile,established,in dengue fever trial,.,Next phase to investigate therapeutic benefits in infected individuals,.,I...

 Watch Recce Pharmaceuticals Secures Australian Patent for Anti-Infectives

Watch Recce Pharmaceuticals Secures Australian Patent for Anti-Infectives

November 27, 2024 11:12 AM AEDT| By Team Kalkine Media

Highlights,Recce Pharmaceuticals gains Australian patent protection for key anti-infective assets,.,Patent extends coverage of RECCE® 327 and RECCE® 529 until 2037,.,Advances intellectual property across major markets, supporting innovative therapies...

 Immutep (ASX:IMM) Advances Clinical Trials and Strengthens Strategic Partnerships

Immutep (ASX:IMM) Advances Clinical Trials and Strengthens Strategic Partnerships

November 26, 2024 04:37 PM AEDT| By Team Kalkine Media

Highlights,Immutep,IMM reports progress in clinical trials targeting autoimmune diseases.,Collaboration with Merck bolsters research and development efforts.,The company focuses on expanding its therapeutic pipeline and achieving new milestones.,Adva...

 Innovative Anti-Infective Treatments Secure Full Patent Protection

Innovative Anti-Infective Treatments Secure Full Patent Protection

November 26, 2024 03:52 PM AEDT| By Team Kalkine Media

Highlights,Recce Pharmaceuticals Ltd secures complete patent protection for two anti-infective treatments.,Australian Patent Office grants "Patent Family 3" status to RECCE 327 and RECCE 529.,Patents provide global protection for manufacturing and ad...

 Biotech Double-Banger Shakes Up IPO Market

Biotech Double-Banger Shakes Up IPO Market

November 26, 2024 03:43 PM AEDT| By Team Kalkine Media

Highlights:,Two life sciences companies, Vitrafy and Renerve, debuted today with mixed initial performances.,Vitrafy’s cryogenic service technology, approved by the FDA, gained some traction, while Renerve’s nerve repair products face production chal...

 BPH Global Expands Seaweed R&D with Gaia Mariculture

BPH Global Expands Seaweed R&D with Gaia Mariculture

November 26, 2024 03:17 PM AEDT| By Team Kalkine Media

Highlights,BPH Global reappoints Gaia Mariculture for advanced seaweed R&D in Singapore.,Scope includes AI, blockchain integration, and sustainable farming innovations.,Research to explore seaweed's role in critical mineral extraction and carbon capt...

 Key Developments and Alliances at Immutep Noted

Key Developments and Alliances at Immutep Noted

November 26, 2024 03:11 PM AEDT| By Team Kalkine Media

Highlights:,Immutep Limited achieves significant progress in autoimmune disease treatments.,Landmark partnership with Merck enhances development capabilities.,Promising clinical trial results pave the way for future advancements.,In a year marked by...

 EZZ Life Sciences has referred to the Chinese consumer market as a thing of beauty

EZZ Life Sciences has referred to the Chinese consumer market as a thing of beauty

November 25, 2024 04:57 PM AEDT| By Team Kalkine Media

Highlights:,EZZ Life Sciences (ASX:EZZ) reports strong sales growth during the 11.11 Global Shopping Festival in China, marking a significant improvement over last year.,Truscreen Group (ASX: TRU) signs a deal with Ho Chi Minh City health authorities...

 4DMedical is set to supply lung imaging technology to a US radiology company after winning the contract

4DMedical is set to supply lung imaging technology to a US radiology company after winning the contract

November 25, 2024 04:44 PM AEDT| By Team Kalkine Media

Highlights:,4DMedical (ASX:4DX) has secured a contract with Imaging Partners of Orange County (IPOC) for lung ventilation and density analysis using CT scans.,The contract, extending through March 2026, marks 4DMedical’s first deal with an independen...

 Revolutionizing Cervical Cancer Screening: TruScreen Group’s Initiative in Vietnam

Revolutionizing Cervical Cancer Screening: TruScreen Group’s Initiative in Vietnam

November 25, 2024 04:17 PM AEDT| By Team Kalkine Media

Highlights,TruScreen,Group to launch a five-year cervical screening program in Vietnam,.,Partnership,established,with Ho Chi Minh City Public Health Association and Gorton Health Services,.,Program aims to screen around,260,000 women,using innovative...

 Neurotech Advances NTI164 Research with New Pharmacokinetic Study

Neurotech Advances NTI164 Research with New Pharmacokinetic Study

November 25, 2024 03:04 PM AEDT| By Team Kalkine Media

Highlights,Neurotech initiates a new study following FDA decision,.,Focus is on NTI164's pharmacokinetics in healthy adults,.,Study results expected by the first quarter of 2025,.,Neurotech (ASX:NTI) has moved forward with a new baseline data study f...

 4DMedical Signs Key Commercial Contract with Imaging Partners of Orange County, Shares Rise 3.3%

4DMedical Signs Key Commercial Contract with Imaging Partners of Orange County, Shares Rise 3.3%

November 25, 2024 01:38 PM AEDT| By Team Kalkine Media

Highlights,Partnership,: 4DMedical has secured a,commercial contract,with,Imaging Partners of Orange County (IPOC),for CT LVAS™ and Lung Density Analysis™ (LDAf) scans.,Significant Milestone,: This is the company’s first contract with an independent...

 Anteris Technologies Sets Eyes on NASDAQ with Early-Stage IPO Filing

Anteris Technologies Sets Eyes on NASDAQ with Early-Stage IPO Filing

November 25, 2024 01:28 PM AEDT| By Team Kalkine Media

Highlights,Anteris,Technologies files preliminary paperwork for potential NASDAQ listing,.,Focus,remains,on flagship next-gen heart valve technology and R&D activities,.,Australian companies are increasingly exploring US markets for liquidity options...

 Pro Medicus Shares Hit Record High Amid Strong Growth Outlook

Pro Medicus Shares Hit Record High Amid Strong Growth Outlook

November 25, 2024 11:52 AM AEDT| By Team Kalkine Media

Highlights,Record Performance,: Pro Medicus shares surged to a record high of AU$226.79 on Monday, marking a 160% increase year-over-year.,Impressive Financials,: FY24 saw revenue grow by 29.3% and net profit after tax by 36.5%.,Growth Opportunities,...

 CSL Shares See Uptick Amid Downplayed Policy Concerns

CSL Shares See Uptick Amid Downplayed Policy Concerns

November 22, 2024 07:03 PM AEDT| By Team Kalkine Media

Highlights,Shares of gain traction following reassessment of US policy risks.,CSL’s vaccine business and broader pharmaceuticals face limited potential impact.,Plasma collection and essential products bolster CSL’s resilience in uncertain times.,CSL...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.